Investments (#)


    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.


    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.

    Recent transactions in the sector

    Country Funding round Date
    Maven Clinic Co
    Women and family health virtual clinic.
    United States Series F
    USD 125,000,000 (USD 125,000,000) at USD 1,700,000,000 (USD 1,700,000,000) valuation.
    8 Oct 2024
    Judo Bio Inc
    Developer of oligonucleotide medicines delivered to the kidney.
    United States Series A
    USD 100,000,000 (USD 100,000,000)
    7 Oct 2024
    Doccla Ltd
    Provider of virtual ward and remote patient monitoring solutions.
    United Kingdom Series B
    GBP 35,000,000
    3 Sep 2024
    Slingshot AI
    Mental health company.
    United States Seed
    USD 30,000,000 (USD 30,000,000)
    22 Aug 2024
    Bedal International NV
    Belgium N/A
    USD 11,000,000 (USD 11,000,000)
    12 Jul 2024
    Adona Medical Inc
    Developer of heart failure solutions.
    United States Series C
    USD 33,500,000 (USD 33,500,000)
    11 Jul 2024
    BillionToOne Inc
    Genetic testing platform detecting and measuring disease.
    United States Series D
    USD 130,000,000 (USD 130,000,000) at USD 1,000,000,000 (USD 1,000,000,000) valuation.
    24 Jun 2024
    Eden Health Inc
    Primary care and insurance navigation company.
    United States Acquisition
    22 May 2024
    Ajax Therapeutics Inc
    Blood cancer biotech.
    United States Series C
    USD 95,000,000 (USD 95,000,000)
    13 May 2024
    May Health
    Medical device company focused on endocrine disorder polycystic ovary syndrome.
    France Series B
    USD 25,000,000 (USD 25,000,000)
    13 May 2024
    ArkeaBio Corp
    Developer of a vaccine to reduce livestock methane emissions.
    United States Series A
    USD 26,500,000 (USD 26,500,000)
    10 May 2024
    Zephyr AI Inc
    Precision medicine startup.
    United States Series A
    USD 111,000,000 (USD 111,000,000)
    13 Mar 2024
    Ambience Healthcare Inc
    "AI operating system" for health care organisations.
    United States Series B
    USD 70,000,000 (USD 70,000,000)
    6 Feb 2024
    Via Scientific Inc
    Developer of a multi-omics platform.
    N/A
    USD 5,000,000 (USD 5,000,000)
    9 Jan 2024
    Calliditas Therapeutics AB
    Biopharma company focused on identifying, developing, and commercialising novel treatments in orphan indications with significant unmet medical needs.
    Sweden Debt
    EUR 92,000,000
    27 Dec 2023
    Parse Biosciences
    Provider of single-cell sequencing solutions.
    United States Series C
    USD 50,000,000 (USD 50,000,000)
    15 Dec 2023
    Parse Biosciences
    Provider of single-cell sequencing solutions.
    United States Debt
    15 Dec 2023
    Vivodyne Inc
    Philadelphia-based biotech that tests its drug candidates on lab-grown human organs.
    United States Seed
    USD 38,000,000 (USD 38,000,000)
    22 Nov 2023
    Doccla Ltd
    Provider of virtual ward and remote patient monitoring solutions.
    United Kingdom N/A
    21 Nov 2023
    Atom Limbs Inc
    Innovator in prosthetic technology.
    Crowdfunding - Equity
    21 Nov 2023
    Healthtech-1 Ltd
    Automating repetitive processes in healthcare.
    United Kingdom Seed
    2023
    Midi Health Inc
    Virtual women's hormone care clinic.
    United States Seed
    USD 14,000,000 (USD 14,000,000)
    31 Oct 2022
    Brightline Inc
    Mental telehealth startup focused on young people.
    United States Series C
    USD 105,000,000 (USD 105,000,000) at USD 600,000,000 (USD 600,000,000) valuation.
    30 Mar 2022
    Doccla Ltd
    Provider of virtual ward and remote patient monitoring solutions.
    United Kingdom Series A
    2022
    Clinikally Digital Health Pvt Ltd
    India's telemedicine platform and online pharmacy for dermatology care.
    India Seed
    2022
    Atom Limbs Inc
    Innovator in prosthetic technology.
    Grant
    19 Dec 2021
    Atom Limbs Inc
    Innovator in prosthetic technology.
    Pre Seed
    22 Apr 2021
    Small Door Veterinary
    Veterinary care company.
    United States Series A
    USD 20,000,000
    21 Apr 2021
    Parse Biosciences
    Provider of single-cell sequencing solutions.
    United States N/A
    USD 7,000,000 (USD 7,000,000)
    27 Jan 2021
    Maridose LLC
    Biotech - Cannabis R&D. We are a US DEA licensed manufacturer of Schedule 1 drugs.
    United States Pre Seed
    USD 150,000 (USD 150,000)
    1 Jan 2021
    Doccla Ltd
    Provider of virtual ward and remote patient monitoring solutions.
    United Kingdom Seed
    2021
    Abalone Bio
    Antibody drug discovery.
    United States Seed
    31 Dec 2020
    Whisper.ai Inc
    Developer of hearing aids.
    United States Series B
    USD 35,000,000 (USD 35,000,000)
    16 Oct 2020
    Atom Limbs Inc
    Innovator in prosthetic technology.
    SAFE
    1 Apr 2020
    Modern Healthcare Inc
    United States Series B
    USD 31,000,000 (USD 31,000,000)
    16 Jan 2020
    Gilgamesh Pharmaceuticals Inc
    Novel psychedelic-Inspired therapeutics for treating mental illness.
    United States Seed
    31 Dec 2019
    Digi-Prex
    Online subscription pharmacy that deliver patients with chronic diseases their prescriptions.
    India Seed
    USD 5,500,000 (USD 5,500,000)
    20 Sep 2019
    Babylon Health Services Ltd
    United Kingdom Series C
    USD 550,000,000 (USD 550,000,000) at USD 1,500,000,000 (USD 1,500,000,000) valuation.
    2 Aug 2019
    Shire PLC
    Ireland Acquisition
    8 Jan 2019
    Auris Health Inc
    United States Acquisition
    USD 3,400,000,000 (USD 3,400,000,000) at USD 3,400,000,000 (USD 3,400,000,000) valuation.
    2019
    1life Healthcare Inc
    A healthcare company focuses on designing innovative health care solutions.
    United States Series C
    USD 220,000,000 (USD 220,000,000)
    22 Aug 2018
    Modern Healthcare Inc
    United States Seed
    USD 2,300,000 (USD 2,300,000)
    15 Jun 2018
    Cambridge Cancer Genomics Ltd
    CCG.ai empowers clinicians to make personalised treatment strategies.
    United Kingdom Seed
    31 Dec 2017
    Ginkgo Bioworks Inc
    DNA design company.
    United States Series D
    USD 275,000,000 (USD 275,000,000) at USD 1,300,000,000 (USD 1,300,000,000) valuation.
    14 Dec 2017
    Auris Surgical Robotics Inc
    United States Venture
    USD 280,000,000 (USD 280,000,000) at USD 1,000,000,000 (USD 1,000,000,000) valuation.
    4 Aug 2017
    4C Medical Technologies Inc
    Medical device company developing minimally invasive therapies for structural heart disease.
    United States Convertible Note
    USD 8,000,000 (USD 8,000,000)
    19 Jul 2017
    ABI Health
    India Seed
    USD 1,500,000 (USD 1,500,000)
    8 Jun 2017
    Babylon Health Services Ltd
    United Kingdom Series B
    USD 47,000,000 (USD 47,000,000) at USD 200,000,000 (USD 200,000,000) valuation.
    25 Apr 2017
    BillionToOne Inc
    Genetic testing platform detecting and measuring disease.
    United States Seed
    2017
    NBE-Therapeutics AG
    Biotech company focused on developing antibody-based treatments for cancer patients.
    Switzerland Series B
    CHF 20,000,000 (USD 20,500,000)
    8 Nov 2016

    Best funded companies in the sector





    Medical equipment manufacturer.

    Investment themes:




    One of the best-known health-care brands in the world and offers one of the most comprehensive product portfolios in the ophthalmic industry.





    Biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases.





    Provider of life-saving medicines for life-threatening diseases.





    A medical device company focused on dual-optic accommodating intraocular lens, called Synchrony, for the treatment of age-related vision loss.





    A healthcare company focuses on designing innovative health care solutions.





    Mental telehealth startup focused on young people.





    Blood cancer biotech.

    Investment themes:




    "AI operating system" for health care organisations.





    Women and family health virtual clinic.





    Medical device company that develops electrosurgical blade system for hospitals and clinics.





    Philadelphia-based biotech that tests its drug candidates on lab-grown human organs.





    Precision medicine startup.





    Developer of oligonucleotide medicines delivered to the kidney.





    Developer of genomic testing systems.

    Investment themes:




    Mental health company.





    Provider of single-cell sequencing solutions.

    Investment themes:




    Developer of a vaccine to reduce livestock methane emissions.

    Investment themes:




    Dublin-based life sciences startup.

    Investment themes:




    Developer of hearing aids.

    Investment themes:




    Developer of heart failure solutions.





    Medical device company developing minimally invasive therapies for structural heart disease.





    Virtual women's hormone care clinic.

    Investment themes:




    Manufacturer of ultrasound devices

    Investment themes:




    Medical device company focused on endocrine disorder polycystic ovary syndrome.

    Investment themes:




    Developer of protein chips.

    Investment themes:




    Online subscription pharmacy that deliver patients with chronic diseases their prescriptions.





    Biotechnology company pioneering controlled combination medicines that overcome the limitations of conventional combination therapy.

    Investment themes:




    Biotech company focused on developing antibody-based treatments for cancer patients.





    Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases.





    Developer of a multi-omics platform.





    Focused on developing neurostimulation therapies based on Nerve Block for patients with chronic pain conditions


    Top investors in the Healthcare sector

    Profile Country Investments
    SV Health Investors LLP 19
    Y Combinator American technology startup accelerator. United States 14
    Essex Woodlands Health Ventures Inc United States 6
    Kleiner Perkins Caufield & Byers LLC Venture capital firm. United States 5
    Versant Ventures Management LLC Venture capital firm focused on making investments in the healthcare and biotechnology industries. United States 5
    Frazier Healthcare Ventures Investment firm providing growth and venture capital to healthcare companies. United States 4
    Third Rock Ventures LLC Venture capital firm focused on building healthcare companies United States 4
    Forbion Capital Partners Management Services BV Netherlands 4
    MPM Capital United States 4
    Prospect Venture Partners Venture capital firm United States 4
    Khosla Ventures Venture capital firm founded by Vinod Khosla. United States 4
    The Carlyle Group LP United States 4
    Adams Street Partners LLC Private equity and venture capital fund of funds United States 4
    ARCH Venture Partners LP Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startup United States 4
    Novartis Services Inc United States 3
    Alta Partners LP Venture capital firm based in San Francisco which invests primarily in biotechnology and life science companies. United States 3
    Vivo Ventures LLC United States 3
    Venrock Associates The venture capital arm of the Rockefeller Family. United States 3
    Beecken Petty O'Keefe & Co Chicago-based private equity management firm investing in middle-market buyout transactions, recapitalizations, and growth platforms in healthcare United States 3
    Triathlon Medical Ventures LLC United States 3
    Johnson & Johnson Innovation LLC Accelerator of early-stage innovation worldwide that forms collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. United States 3
    Perseus LLC Merchant bank and private equity fund management company. United States 3
    Novartis Venture Funds The corporate venturing arm of Novartis. Switzerland 3
    BioEnterprise United States 3
    ePlanet Capital United States 3
    TVM Capital Corp United States 3
    Venture Investors LLC United States 3
    Kaiser Permanente Ventures The corporate venturing arm of Kaiser Permanente. 3
    New Leaf Venture Partners United States 3
    Sequoia Capital Operations LLC Venture capital firm. United States 3
    North Coast Angel Fund United States 3
    EDF Ventures United States 3
    Hercules Technology Growth Capital Inc Specialised finance company providing debt and equity growth capital to technology-related companies at all stages of development. United States 2
    Morgenthaler Management Partners One of the oldest private equity investment firms in the US investing through both venture capital and leverage buyout transactions. United States 2
    Andreessen Horowitz Venture capital firm founded by Marc Andreessen and Ben Horowitz United States 2
    MPM Asset Management LLC United States 2
    Mithril Capital Management LLC United States 2
    Afore Capital Management LLC Venture capital firm. United States 2
    Gilead Sciences Inc A biopharmaceutical company that discovers, develops and commercializes therapeutics. United States 2
    Quiet Capital Management LLC United States 2
    Cressey & Co United States 2
    CMEA Capital United States 2
    Glengary Ventures LLC United States 2
    Waud Capital Partners LLC United States 2
    VantagePoint Capital Partners Venture capital firm with investments in the cleantech, information technology, and healthcare sectors. United States 2
    ProQuest Investments United States 2
    Blue Chip Venture Co United States 2
    Viking Global Investors LP 2
    Spray Venture Partners United States 2
    Bioeconomy Capital United States 2

    Top acquirers in the Healthcare sector

    Profile Country Acquisitions
    Abbott Laboratories United States 3
    Pfizer Inc United States 2
    Medtronic Inc Medical technology company specializing in implantable and invasive therapies. United States 2
    Johnson & Johnson Corp 2
    Takeda Pharmaceutical Co Ltd 2
    Roche Holding AG 2
    Eli Lilly & Co 2
    Ampersand Ventures United States 1
    Valeant Pharmaceuticals International 1
    Nestlé SA Switzerland 1
    Bayer AG Germany 1
    Centivo Corp Health plan for self-funded employers. 1
    Shire PLC Ireland 1
    Mallinckrodt United States 1
    Abbvie Inc United States 1
    BioMarin Pharmaceutical Inc United States 1
    Fresenius Medical Care 1
    Viatris 1
    Amgen Inc United States 1
    TC Group LLC A global alternative asset manager investing across three asset classes - private equity, real estate and credit alternatives United States 1

    Healthcare industry map

    CBD

    See all CBD
    Purtier Placenta
    care homes

    See all care homes
    telehealth

    See all telehealth
    wellness

    See all wellness
    bacterial infections
    subscription veterinary
    cows

    See all cows

    Healthcare selected pre-money valuations (USD)

    Funding round Median Average Minimum Maximum Sample size
    Series B 200,000,000 200,000,000 200,000,000 200,000,000 1
    Series C 1,050,000,000 1,050,000,000 600,000,000 1,500,000,000 2
    Series D 1,150,000,000 1,150,000,000 1,000,000,000 1,300,000,000 2
    Series F 1,700,000,000 1,700,000,000 1,700,000,000 1,700,000,000 1
    Venture 1,000,000,000 1,000,000,000 1,000,000,000 1,000,000,000 1
    Acquisition 6,366,810,000 12,908,224,091 113,000,000 68,000,000,000 22
    113,000,000 68,000,000,000 29

    DISCLAIMER: This table is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.

    Healthcare selected deal sizes (USD)

    Funding round Median Average Minimum Maximum Sample size
    Convertible Note 8,000,000 8,000,000 8,000,000 8,000,000 1
    Pre Seed 150,000 150,000 150,000 150,000 1
    Seed 9,750,000 15,216,667 1,500,000 38,000,000 6
    Series A 25,750,000 41,418,750 350,000 111,000,000 8
    Series B 25,000,000 27,587,273 4,000,000 70,000,000 11
    Series C 100,000,000 164,785,714 33,500,000 550,000,000 7
    Series D 130,000,000 148,333,333 40,000,000 275,000,000 3
    Series E 30,000,000 30,000,000 30,000,000 30,000,000 1
    Series F 125,000,000 125,000,000 125,000,000 125,000,000 1
    Venture 16,500,000 70,300,000 12,000,000 280,000,000 5
    Acquisition 5,600,000,000 12,351,996,957 113,000,000 68,000,000,000 23
    N/A 9,500,000 20,000,000 5,000,000 65,000,000 6
    73

    DISCLAIMER: This table is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.